Merck & Co., Inc. (6MK.DE)

EUR 73.9

(-1.2%)

Operating Income Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual operating income in 2023 was 2.95 Billion USD , down -75.09% from previous year.
  • Merck & Co., Inc.'s latest quarterly operating income in 2024 Q2 was 6.38 Billion USD , up 0.79% from previous quarter.
  • Merck & Co., Inc. reported an annual operating income of 14.71 Billion USD in 2022, up 38.17% from previous year.
  • Merck & Co., Inc. reported an annual operating income of 10.64 Billion USD in 2021, up 95.84% from previous year.
  • Merck & Co., Inc. reported a quarterly operating income of 6.08 Billion USD for 2024 Q1, up 528.47% from previous quarter.
  • Merck & Co., Inc. reported a quarterly operating income of -4.86 Billion USD for 2023 Q2, down -225.38% from previous quarter.

Annual Operating Income Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual Operating Income of Merck & Co., Inc. (2023 - 1989)

Year Operating Income Operating Income Growth
2023 2.95 Billion USD -75.09%
2022 14.71 Billion USD 38.17%
2021 10.64 Billion USD 95.84%
2020 5.43 Billion USD -41.09%
2019 9.22 Billion USD 3.31%
2018 8.93 Billion USD 22.19%
2017 7.3 Billion USD 21.21%
2016 6.03 Billion USD -20.1%
2015 7.54 Billion USD 12.93%
2014 6.68 Billion USD -12.81%
2013 7.66 Billion USD -22.4%
2012 9.87 Billion USD 10.04%
2011 8.97 Billion USD 167.54%
2010 3.35 Billion USD -16.57%
2009 4.02 Billion USD -33.92%
2008 6.08 Billion USD 8.33%
2007 5.61 Billion USD 52.38%
2006 3.68 Billion USD -37.08%
2005 5.85 Billion USD -11.53%
2004 6.62 Billion USD -21.69%
2003 8.45 Billion USD -12.53%
2002 9.66 Billion USD -0.62%
2001 9.72 Billion USD 7.03%
2000 9.08 Billion USD 19.68%
1999 7.59 Billion USD 19.11%
1998 6.37 Billion USD 12.52%
1997 5.66 Billion USD 13.68%
1996 4.98 Billion USD 13.2%
1995 4.4 Billion USD -0.03%
1994 4.4 Billion USD 13.37%
1993 3.88 Billion USD 11.29%
1992 3.49 Billion USD 12.28%
1991 3.1 Billion USD 17.29%
1990 2.65 Billion USD 18.56%
1989 2.23 Billion USD 19.79%

Peer Operating Income Comparison of Merck & Co., Inc.

Name Operating Income Operating Income Difference
Bayer Aktiengesellschaft -150 Million EUR 2069.333%
Sanofi 7.87 Billion EUR 62.489%